Search company, investor...

MedidaMetrics

Stage

Dead | Dead

Total Raised

$11.65M

About MedidaMetrics

MedidaMETRICS is a healthcare performance solutions company that provides tools needed to maximize financial performance in a competitive market. MedidaMETRICS provides a rich data base in its ExactCost ABC/ABM solutions that can be used to determine capacity planning, resource allocation, modeling, scenario building, business development, partnership and collaboration assessment, as well as government program support.

Headquarters Location

1350 Beverly Road Suite 115-339

McLean, Virginia, 22101,

United States

954-455-5665

Missing: MedidaMetrics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MedidaMetrics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

MedidaMetrics Frequently Asked Questions (FAQ)

  • Where is MedidaMetrics's headquarters?

    MedidaMetrics's headquarters is located at 1350 Beverly Road, McLean.

  • What is MedidaMetrics's latest funding round?

    MedidaMetrics's latest funding round is Dead.

  • How much did MedidaMetrics raise?

    MedidaMetrics raised a total of $11.65M.

  • Who are the investors of MedidaMetrics?

    Investors of MedidaMetrics include Flagship Pioneering and NGN Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.